- What Is A MGP, Exactly?
- Who Holds This Certification (and Who Can't)
- How the MGP Exam Actually Works
- The 17 Domains an MGP Must Master
- Eligibility Before You Even Apply
- Life After Passing: Keeping the Certification
- Why This Credential Matters on the Job
- A Realistic Way to Prepare
- Frequently Asked Questions
- MGP is a joint ABPath/ABMGG subspecialty exam, not a standalone lab credential.
- The 2026 exam runs 245 questions across six sections, testing at Pearson VUE centers in person.
- Solid Tumors (11%), Inherited Diseases (10%), and Hematopathology (9%) are the three heaviest domains.
- The 2026 fee is USD 2,100, including a nonrefundable USD 200 administrative charge.
What Is A MGP, Exactly?
A MGP is a physician who holds Certification in Pathology: Molecular Genetic Pathology, a subspecialty credential jointly administered by the American Board of Pathology (ABPath) and the American Board of Medical Genetics and Genomics (ABMGG). It is not a laboratory technologist certification, and it is not the same as any other credential that happens to share the letters "MGP." If you're comparing this to something else you saw online, stop - MGP Meaning and What Does MGP Stand For? both walk through the naming confusion in more depth, but on this site MGP always refers to the ABPath/ABMGG physician exam.
This site, and specifically MGP Exam Prep, focuses on the initial physician MGP examination pathway - not the Laboratory Genetics and Genomics certification track. That distinction matters because the two credentials serve different roles in a molecular diagnostics lab, and preparing for the wrong one wastes months of study time.
Who Holds This Certification (and Who Can't)
You can't sit for the MGP exam straight out of residency. Candidates must already hold qualifying primary ABPath certification in AP/CP, AP, or CP, or an eligible ABMGG physician certification. On top of that base credential, candidates need 12 months of ACGME-accredited Molecular Genetic Pathology fellowship training, plus the standard medical education, licensure, and training-verification requirements ABPath applies to every subspecialty. For the full checklist, see MGP Requirements 2026: Eligibility, Prerequisites & How to Qualify.
In practice, that means MGP is a second (or third) board certification layered on top of an existing pathology or medical genetics identity - the people sitting for this exam are already practicing physicians, often molecular fellows finishing their training year, not new graduates exploring career options.
How the MGP Exam Actually Works
The MGP exam is a computer-based, single-best-answer multiple-choice test that also incorporates written/practical material - meaning you'll see image-based and data-interpretation items, not just text stems. For the 2026 cycle, the exam contains 245 questions spread across six sections, with 6 hours and 34 minutes of active testing time. Once you add instructions, a survey, and scheduled breaks, the total day runs about 9 hours and 4 minutes.
Unlike some remotely proctored credentials, MGP testing happens in person at Pearson VUE Professional Centers. You cannot take this exam from your home office, so factor travel and a testing-center day into your planning. For the exact calendar and application deadlines, check MGP Exam Dates 2026: Testing Windows, Deadlines & Scheduling.
Passing Isn't a Percentage Game
ABPath uses a scaled score with a passing standard of 500 - there is no fixed "70% correct" target to chase. That distinction trips up candidates who try to reverse-engineer a raw score threshold. In 2025, ABPath reported 50 of 56 examinees passed overall (89%), and 45 of 49 first-time examinees passed (92%). Those numbers describe outcomes, not a formula you can use to predict your own result - see MGP Pass Rate 2026: What the Data Shows and MGP Passing Score 2026: Exactly What You Need to Pass for how the scaled scoring actually functions.
The 17 Domains an MGP Must Master
The 2026 blueprint organizes content into 17 domains with approximate percentage weights. Nothing here is guesswork on our part - these are the official allocations, and they should directly shape how you divide study time.
Domain 10: Solid Tumors (11%)
The single largest domain. Expect questions on tumor-specific molecular alterations, targeted therapy biomarkers, and how somatic findings differ from germline results in the same specimen.
- Distinguishing actionable driver mutations from passenger variants
- Correlating molecular findings with histology and staging
Domain 8: Inherited Diseases (10%)
Second-largest domain, covering Mendelian and complex inherited conditions.
- Pedigree interpretation and inheritance pattern reasoning
- Variant classification frameworks for germline findings
Domain 11: Hematopathology (9%)
Third-largest domain, focused on molecular testing in leukemias, lymphomas, and myeloid neoplasms.
- Clonality assays and minimal residual disease monitoring
- Fusion transcripts and their diagnostic/prognostic weight
The remaining domains carry smaller but still testable weights: Normal Structure and Function (7%), Molecular Genetic Principles (7%), Assay Performance and Validation (7%), Quality (6%), Infectious Disease (6%), Techniques and Methods (5%), Ethical, Legal, and Regulatory Issues (5%), Inherited Cancer Syndromes (5%), Pharmacogenetics (5%), Indications for Testing (4%), Identity Testing (4%), Informatics (4%), Management and Informatics-General (3%), and Histocompatibility (2%). Even the smallest domains are worth reviewing because a handful of missed items across several low-weight areas adds up. A complete walkthrough of all 17 areas, including topic-by-topic study notes, is available in MGP Exam Domains 2026: Complete Guide to All 17 Content Areas.
Key Takeaway
Don't split study time evenly across all 17 domains. Weight your hours toward Solid Tumors, Inherited Diseases, and Hematopathology first - together they account for roughly 30% of the exam.
What "MGP Question Style" Actually Looks Like
Because the exam blends written and practical material, expect prompts built around real molecular laboratory data: sequence traces, array results (copy number calls), karyotypes, and pedigrees presented as figures you must interpret before answering. A recurring skill tested throughout multiple domains is distinguishing germline versus somatic findings, separating infectious-disease molecular signatures from human genomic ones, and reasoning about laboratory-method limitations (why a particular assay might miss a variant type, for example). This is less about memorizing gene names and more about applying molecular logic to a dataset in front of you.
Eligibility Before You Even Apply
Before you pay the application fee, confirm three things: your primary ABPath certification (AP/CP, AP, or CP) or eligible ABMGG certification is active, your 12-month ACGME-accredited MGP fellowship is documented, and your training-verification paperwork is ready to submit. Missing documentation is one of the most avoidable reasons applications stall. Review the specifics in MGP Requirements 2026: Eligibility, Prerequisites & How to Qualify well before your intended exam date so there's time to resolve gaps.
| Item | 2026 Detail |
|---|---|
| Certifying bodies | ABPath and ABMGG (joint subspecialty) |
| Application/exam fee | USD 2,100 (includes USD 200 nonrefundable admin fee) |
| Question count | 245 questions across six sections |
| Active testing time | 6 hours 34 minutes |
| Total scheduled time | 9 hours 4 minutes |
| Testing location | Pearson VUE Professional Centers (in person) |
| Passing standard | Scaled score of 500 |
| Fellowship requirement | 12 months, ACGME-accredited MGP program |
Life After Passing: Keeping the Certification
Current ABPath certificates carry no fixed expiration date, but they remain conditional on ongoing Continuing Certification participation. For ABPath diplomates, that means biennial PATHway reporting, maintaining professional standing, and demonstrating lifelong learning and practice improvement. The standard route requires 70 qualifying CME credits per two-year reporting period, with at least 80% of those credits related to your scope of practice; approved training and research alternatives exist for physicians whose work doesn't map cleanly onto typical CME categories.
ABPath also offers CertLink, a quarterly, low-stakes assessment model with a cumulative performance requirement of at least 60% averaged over four years - an alternative to a single high-stakes recertification exam. Note that these Continuing Certification rules apply specifically to ABPath diplomates; if your primary certification is through ABMGG, you'll follow ABMGG's own maintenance requirements instead. Passing the initial exam is a milestone documented well by MGP Certification, but it's genuinely the start of an ongoing reporting relationship, not a one-time event.
Why This Credential Matters on the Job
Employers hiring for molecular pathology director roles, academic medical center genomics labs, and reference laboratory positions increasingly list MGP certification (or fellowship eligibility toward it) as a preferred or required qualification. It signals that a physician can independently validate assays, sign out molecular reports, and take responsibility for the accuracy of genomic-based diagnoses under CLIA-regulated lab directorship structures. For a broader look at where these positions exist and what they typically require, see MGP Jobs.
Whether the credential is "worth it" for a given career depends on practice setting, existing board certifications, and long-term goals - that cost-benefit question deserves its own analysis rather than a quick answer here; Is the MGP Certification Worth It? Complete ROI Analysis 2026 and MGP Salary Guide 2026: Complete Earnings Analysis both dig into that decision using verifiable data rather than assumptions.
A Realistic Way to Prepare
Generic study advice (spaced repetition, timed blocks, practice-question rotation) only helps if it's mapped onto MGP's actual content weighting. A workable approach: spend early weeks building foundational fluency in Molecular Genetic Principles and Techniques and Methods, since those concepts underpin every later domain, then move into the heavyweight clinical domains.
Foundations
- Molecular Genetic Principles and Techniques and Methods
- Assay Performance and Validation basics
Heavyweight Clinical Domains
- Solid Tumors (11%) - driver mutations, targeted therapy markers
- Inherited Diseases (10%) - pedigrees, variant classification
- Hematopathology (9%) - clonality, fusion transcripts
Mid-Weight Domains
- Normal Structure and Function, Quality, Infectious Disease
- Inherited Cancer Syndromes, Pharmacogenetics
Lower-Weight Domains + Full Review
- Identity Testing, Histocompatibility, Informatics, Management
- Timed practice sets mimicking the 245-question, six-section format
For a structured week-by-week plan built entirely around this blueprint, see MGP Study Guide 2026: How to Pass on Your First Attempt. If you want a candid assessment of exam difficulty before you commit to a timeline, How Hard Is the MGP Exam? Complete Difficulty Guide 2026 covers what makes this exam demanding beyond raw content volume. And when exam day approaches, running through timed practice sets on our practice test platform is the closest simulation to the real 245-question, six-section format you'll get outside Pearson VUE itself.
Frequently Asked Questions
It's a subspecialty certification layered on top of an existing primary certification - either ABPath (AP/CP, AP, or CP) or an eligible ABMGG credential. You cannot pursue MGP as your first board certification.
No. Testing takes place in person at Pearson VUE Professional Centers; there is no at-home remote proctoring option for this exam.
The 2026 exam has 245 questions across six sections, with 6 hours 34 minutes of active testing and about 9 hours 4 minutes of total scheduled time including breaks and instructions.
ABPath uses a scaled score with a passing standard of 500 rather than a fixed raw percentage. See MGP Passing Score 2026: Exactly What You Need to Pass for more detail on how scaling works.
Solid Tumors (11%), Inherited Diseases (10%), and Hematopathology (9%) carry the highest weight in the 2026 blueprint and deserve proportionally more study time than the smaller domains.